<!DOCTYPE html>

<html lang="en">

<head>
    <!-- Google tag (gtag.js) -->
    <script async src="https://www.googletagmanager.com/gtag/js?id=G-6DMWTLD8G4"></script>
    <script>
    window.dataLayer = window.dataLayer || [];
    function gtag(){dataLayer.push(arguments);}
    gtag('js', new Date());

    gtag('config', 'G-6DMWTLD8G4');
    </script>

    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" href="../style.css"/>
    <title>Nadia Nasreddin - Abstract</title>
</head>

<body>
    <div class="header">
        <div class="name">Nadia Nasreddin</div>
    </div>

    <div class="first">
        <div class="title">WNT Alterations in CRC: Selfish <em>Apc</em> VS Altruistic <em>Rspo</em>?</div>
        <div class="cont">
            <img class="fluor" src="../images/fluor.jpg">
        </div> 
    </div>

    <div class="nav">
            <a href="../index.html">Biography</a>
            <a class="live" href="./abstract.html">Abstract</a>
            <a href="./wnt.html">WNT Pathway</a>
    </div>

    <div class="second">
        <div class="content">
            <div class="abstract-text">
                <h3><b>Nadia Nasreddin</b>, Nuray Gunduz, Hayley L Benoue-Davis, Amelia Ligenza, Gabriel N Valbuena, Ester Gil Vasquez, Lai Mun Wang, Alistair Easton, Maurice B Loughrey, Kane Smith, Dustin J Flanagan, Salpie Nowinski, Ibrahim Al-Bakir, Sulochana Omwenga, Kathryn Gilroy, Rachel A Ridgway, Andrew Campbell, Mark Hughes, Colin Nixon, Silvia Martinelli, Tim S Maughan, Trevor A Graham, Simon J Leedham, Owen J Sansom</h3>
                <p>
                    Aberrant WNT pathway activation is a hallmark of colorectal cancer. The principal mechanism of WNT hyperactivation is mutation of key WNT-genes, i.e.  loss-of-function mutations in <em>APC</em> and <em>RNF43</em> and gain-of-function mutations in <em>CTNNB1</em> and <em>RSPO</em>. Recent studies have shown that <em>Apc</em> mutations in Lgr5-positive cells give rise to super-competitor cells, whereby mutant cells hold an endogenous fitness advantage provided by the intrinsic and constitutive WNT activation, coupled with suppression of neighbouring wild-type cells’ stemness and promotion of their differentiation though secretion of Notum. This allows <em>Apc</em>-mutant cells to “fix” and outcompete wild-type cells. However, the dynamics between <em>Rspo</em>-mutant, <em>Rnf43</em>-mutant and <em>Ctnnb1</em>-mutant cells, and their respective neighbours is yet to be described.  
                </p>   
                <p>
                    In this study, the cell dynamics between Rspo3-mutant cells and their wild-type neighbours was investigated. Contrary to the profound NOTUM expression seen in <em>APC</em>-mutant lesions, no expression of NOTUM was found in the <em>RSPO3</em>-mutant lesions, in both human and mouse samples, suggesting that <em>RSPO3</em>-mutant cells do not suppress their neighbouring cells’ stemness. Furthermore, the assessment of <em>Apc</em>-mutant and <em>Rspo3</em>-overexpressing murine models showed a dramatic increase in Paneth cells (PCs) in the <em>Rspo3</em>-mutant models.  Investigation of this in a case-control, multiple timepoint mouse experiment revealed that Rspo3 expression caused an expansion of PCs, with overexpression of Rspo3 in Lgr5-negative cells favouring skewing of secretory cell fate towards PCs. The expansion of PCs is believed to be mediated through Lgr4-positive cells. Notably, <em>Apc</em> mutation in Atoh1-positive cells did not have an impact on secretory cells, highlighting that the Paneth cell hyperplasia seen is specific to Rspo3 overexpression. Lastly, cell competition experiments showed that whilst <em>Apc</em>-mutant cells colonise the crypt overtime, outcompeting wild-type cells, <em>Rspo3</em>-mutant cells, allow for the co-expansion of both Rspo3-positive and Rspo3-negative Lgr5-positive clones. Based on these observations an <em>Apc</em> selfish versus <em>Rspo</em> altruistic cell dynamics model is proposed.
                </p>   
            </div>
        </div>
        <div class="content">
            <div class="abstract-image">
                <h4>Working Hypothesis</h4>
                <img class="abstract" src="../images/pictoral_hypothesis.png" alt="Graphical representation of working hypothesis">
            </div>
        </div>
        <div class="content">
            <div class="acknowledgements">
                <h4>Acknowledgements</h4>
                <p>
                    Thank you to Hayley Belnoue-Davis, Dustin Flanagan, Owen Sansom, Simon Leedham, the Leedham and Samson groups, Maurice Loughrey, Colin Nixon, Mark Hughes and everybody that has contributed to this body of work. 

                    Thank you to the FGF Unit at the Wellcome Centre for Human Genetics, The BRC, Cancer Research UK and the Wellcome Centre for Human Genetics.
                </p>
            </div>
        </div>
        <div class="content">
            <div class="key-references">
                <h4>Key References</h4>
                <div class="references">
                    <ul>
                        <li>
                            Krausova, M. & Korinek, V. Wnt signaling in adult intestinal stem cells and cancer. Cellular Signalling 26, 570–579. <a href="https://www.nature.com/articles/s41575-019-0161-7" target="_blank">https://www.nature.com/articles/s41575-019-0161-7</a> (2019).
                        </li>
                        <li>
                            Koch, S. Extrinsic control of Wnt signaling in the intestine. Differentiation 97, 1–8. ISSN: 0301-4681. <a href="https://www.sciencedirect.com/science/article/pii/S0301468117300774" target="_blank">https://www.sciencedirect.com/science/article/pii/S0301468117300774</a> (2017).
                        </li>
                        <li>
                            Krausova, M. & Korinek, V. Wnt signaling in adult intestinal stem cells and cancer. Cellular Signalling 26, 570–579. ISSN: 0898-6568. <a href="https://www.sciencedirect.com/science/article/pii/S089865681300363X" target="_blank">https://www.sciencedirect.com/science/article/pii/S089865681300363X</a> (2014).
                        </li>
                        <li>
                            Kleeman, S. O. et al. Exploiting differential Wnt target gene expression to generate a molecular biomarker for colorectal cancer stratification. Gut 69, 1092–1103. ISSN: 0017-5749. <a href="https://gut.bmj.com/content/69/6/1092" target="_blank">https://gut.bmj.com/content/69/6/1092</a> (2020).
                        </li>
                        <li>  
                            Flanagan, D. J. et al. NOTUM from Apc-mutant cells biases clonal competition to initiate cancer. Nature 594, 430–435. <a href="https://www.nature.com/articles/s41586-021-03525-z" target="_blank">https://www.nature.com/articles/s41586-021-03525-z</a> (2021).
                        </li>
                        <li>
                            van Neerven, S. M. et al. Apc-mutant cells act as supercompetitors in intestinal tumour initiation. Nature 594, 436–441. <a href="https://www.nature.com/articles/s41586-021-03558-4" target="_blank">https://www.nature.com/articles/s41586-021-03558-4</a> (2021).
                        </li>
                        <li>
                            Yum, M. K. et al. Tracing oncogene-driven remodelling of the intestinal stem cell niche. Nature 594, 442–447. <a href="https://www.nature.com/articles/s41586-021-03605-0" target="_blank">https://www.nature.com/articles/s41586-021-03605-0</a> (2021).
                        </li>
                    </ul>
                </div>
            </div>
        </div>
    </div>

</body>